
News|Articles|August 1, 2008
FDA Pipeline preview, August 2008
Recent FDA action (through August 2008) related to long-acting depot preparation of testosterone, pancrealipase capsules, human papillomavirus (HPV) quadrivalent (types 6, 11, 16, 18) vaccine, recombinant, tolvaptan, etanercept, ustekinumab, and cysteamine hydrocortisone dual-release table.
Advertisement
Approvable designations
Complete response
Recommended for approval
Newsletter
Get the latest industry news, event updates, and more from Managed healthcare Executive.
Advertisement
Advertisement
Advertisement
Trending on Managed Healthcare Executive
1
Transparency paves the way for lower costs and equitable access
2
New self-injectable biologics promise cost savings and patient convenience
3
World AIDS Day: 10 things to know about AIDS in 2025
4
Evaluating Chronic Kidney Disease as a Risk Factor for Cardiovascular Disease: Written Recap
5






















































